ROY ET AL.
9
3
183, 2990, 1630, 1583, 1449, 1367, 1274, 1191, 949; MS
ethyl
4‐(4‐methoxyphenyl)‐6‐methyl‐2‐oxo‐1,2,3,4‐
+
(
m/z): 231.1 [M ].
tetrahydropyrimidine‐5‐carboxylate (4ao)
Using the general experimental procedure to afford 4ao
1
5
‐acetyl‐4‐(1H‐indol‐3‐yl)‐6‐methyl‐3,4‐
as white solid, (262 mg, 90% yield), M. P.: 208°C, H
dihydropyrimidin‐2(1H)‐one (4ak)
NMR (CDCl and DMSO, 500 MHz): δ 7.49 (s, 1H), 7.24
3
Using the general experimental procedure to afford 4ak
as white solid, (228 mg, 85% yield), M. P.: 222°C, H
(s, 1H), 7.23 (d, 1H, J = 5 Hz), 6.83 (d, 1H, J = 10 Hz),
5.35 (d, 1H, J = 15 Hz), 4.07 (q, 2H, J = 7.5 Hz), 3.78 (s,
3H), 2.34 (s, 3H), 1.17 (t, 3H, J = 5 Hz); C NMR (CDCl
3
1
13
NMR (CDCl , 500 MHz): δ 9.83 (s, 1H), 8.31 (s, 1H),
3
7
7
.56 (d, 1H, J = 10 Hz), 7.35 (d, 1H, J = 10 Hz), 6.88‐
and DMSO, 125 MHz): 165.55, 159.14, 152.67, 145.48,
135.90, 127.72, 113.87, 101.69, 59.96, 55.17, 18.73, 14.06;
FT‐IR (KBR, cm ): 3230, 3121, 1722, 1628, 1543, 1380,
1230, 1040, 799; MS (m/z): 290.1 [M+].
13
.12 (m, 2H), 4.21 (s, 1H), 2.48 (s, 3H), 2.22 (s, 3H);
C
−
1
NMR (CDCl , 125 MHz): 206.42, 157.57, 151.52, 136.33,
3
1
1
1
27.43, 122.41, 122.11, 121.76, 119.11, 119.03, 115.52,
−
1
10.94, 32.11, 22.20, 18.74; FT‐IR (KBR, cm ): 3400,
+
608, 1439, 1239, 1015, 745; MS (m/z): 269.1 [M ].
ethyl
4‐(4‐methoxyphenyl)‐6‐methyl‐2‐thioxo‐1,2,3,4‐
tetrahydropyrimidine‐5‐carboxylate (4bp)
ethyl
4‐(3‐hydroxyphenyl)‐6‐methyl‐2‐oxo‐1,2,3,4‐
Using the general experimental procedure to afford 4bp
as white solid, (2767 mg, 87% yield), M. P.: 218°C, H
1
tetrahydropyrimidine‐5‐carboxylate (4al)
Using the general experimental procedure to afford 4al as
white solid, (263 mg, 95% yield), M. P.: 166°C, H NMR
NMR (CDCl and DMSO, 500 MHz): δ 9.57 (s, 1H),
3
1
8.88 (s, 1H), 7.49 (d, 1H, J = 5 Hz), 6.81 (d, 1H,
J = 10 Hz), 5.29 (d, 1H, J = 3 Hz), 4.07 (q, 2H,
J = 7.5 Hz), 3.82 (s, 3H), 2.92 (s, 3H), 1.18 (t, 3H,
(
CDCl and DMSO, 500 MHz): δ 8.87 (s, 1H), 8.62 (s,
3
1
5
3
1
1
H), 7.09 (d, 1H, J = 10 Hz), 6.88 (d, 1H, J = 10 Hz),
13
.28 (d, 1H, J = 3 Hz), 4.07 (q, 2H, J = 4 Hz), 2.33 (s,
J = 5 Hz); C NMR (CDCl and DMSO, 125 MHz):
3
13
H), 1.19 (t, 3H, J = 5 Hz); C NMR (CDCl and DMSO,
179.11, 170.36, 163.71, 148.90, 140.57, 132.76, 118.41,
3
25 MHz): 165.71, 157.26, 152.68, 152.27, 146.73, 129.31,
106.63, 64.55, 59.86, 59.26, 22.45, 18.78; FT‐IR (KBR,
−
1
17.52, 114.80, 113.56, 55.19, 18.43, 14.01; FT‐IR (KBR,
cm ): 3246, 3115, 1706, 1652, 1514, 1384, 1225, 1089,
−
1
cm ): 3245, 1725, 1643, 1454, 1221, 1091, 777; MS
791; MS (m/z): 306.0 [M+].
+
(
m/z): 276.0 [M ].
ethyl 4‐(4‐hydroxy‐3‐methoxyphenyl)‐6‐methyl‐2‐oxo‐
1,2,3,4‐tetrahydropyrimidine‐5‐carboxylate (4bq)
Using the general experimental procedure to afford 4bq
as yellow solid, (278 mg, 86% yield), M. P.: 238°C, H
NMR (CDCl and DMSO, 500 MHz): δ 9.43 (s, 1H), 8.74
3
ethyl 4‐(4‐hydroxyphenyl)‐6‐methyl‐2‐oxo‐1,2,3,4‐
tetrahydropyrimidine‐5‐carboxylate (4am)
1
Using the general experimental procedure to afford 4am
1
as white solid, (266 mg, 96% yield), M. P.: 193°C, H
NMR (CDCl and DMSO, 500 MHz): δ 8.80 (s, 1H), 8.58
(s, 1H), 6.82 (d, 1H, J = 8 Hz), 6.74‐6.79 (m, 2H), 5.27
(d, 1H, J = 3 Hz), 4.07 (q, 2H, J = 2.0 Hz), 3.84 (s, 3H),
3
(s, 1H), 7.41 (s, 1H), 7.13 (d, 1H, J = 5 Hz), 6.75 (d, 1H,
13
J = 5 Hz), 5.26 (d, 1H, J = 2.5 Hz), 4.05 (q, 2H,
2.35 (s, 3H), 1.18 (t, 3H, J = 1.5 Hz, 1.5 Hz); C NMR
(CDCl and DMSO, 125 MHz): 184.63, 174.28, 165.58,
146.93, 145.73, 134.83, 119.29, 114.81, 110.00, 102.01,
13
J = 5 Hz), 2.32 (s, 3H), 1.16 (t, 3H, J = 5 Hz, 5 Hz);
C
3
NMR (CDCl3 and DMSO, 125 MHz): 165.74, 156.43,
−
1
1
5
1
53.11, 146.62, 135.22, 127.55, 115.07, 100.76, 59.36,
59.80, 55.70, 54.99, 17.74, 13.96; FT‐IR (KBR, cm ):
−
1
4.38, 18.05, 13.92; FT‐IR (KBR, cm ): 3199, 1709,
3246, 3118, 1698, 1645, 1516, 1453, 1222, 1092, 799; MS
+
+
589, 1470, 1310, 1196, 1047, 813; MS (m/z): 276.1 [M ].
(m/z): 322.1 [M ].
ethyl
4‐(4‐hydroxyphenyl)‐6‐methyl‐2‐thioxo‐1,2,3,4‐
ethyl
4‐(2,4‐dichlorophenyl)‐6‐methyl‐2‐oxo‐1,2,3,4‐
tetrahydropyrimidine‐5‐carboxylate (4bn)
tetrahydropyrimidine‐5‐carboxylate (4ar)
Using the general experimental procedure to afford 4bn
as white solid, (263 mg, 91% yield), M. P.: 195°C, H
Using the general experimental procedure to afford 4ar as
white solid, (280 mg, 85% yield), M. P.: 229°C, H NMR
1
1
NMR (CDCl and DMSO, 500 MHz): δ 8.80 (s, 1H), 8.78
(CDCl and DMSO, 500 MHz): δ 8.98 (s, 1H), 7.10‐7.45
3
3
(
1
s, 1H), 8.58 (s, 1H), 7.13 (d, 1H, J = 10 Hz), 6.75 (d,
H, J = 10.0 Hz), 5.26 (d, 1H, J = 2.5 Hz), 4.05 (q, 2H,
J = 4.0 Hz), 2.32 (s, 3H), 1.16 (t, 3H, J = 5 Hz, 5 Hz);
(m, 2H), 6.10 (d, 1H, J = 10 Hz), 5.72 (d, 1H,
J = 10 Hz), 4.10 (q, 2H, J = 5 Hz), 2.21 (s, 3H), 1.28 (t,
13
3H, J = 1.5 Hz);
C NMR (CDCl and DMSO,
3
1
3
C NMR (CDCl and DMSO, 125 MHz): 174.33, 165.73,
125 MHz): 168.69, 153.54, 150.24, 139.51, 133.71, 130.78,
3
1
5
1
57.00, 143.68, 134.37, 128.12, 115.45, 102.41, 59.94,
128.64, 98.92, 58.74, 52.23, 18.72, 11.95; FT‐IR (KBR,
−
1
−1
4.97, 17.87, 14.10; FT‐IR (KBR, cm ): 3207, 1716,
cm ): 3359, 1750, 1454, 1390, 1219, 1110, 809; MS
+
+
585, 1476, 1315, 1189, 1084, 834; MS (m/z): 291.9 [M ].
(m/z): 328.0 [M ].